Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique

429 papers and 21.0k indexed citations i.

About

In recent decades, authors affiliated with Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique have published 429 papers, which have received a total of 21.0k indexed citations. Scholars at this organization have produced 146 papers in Molecular Biology, 69 papers in Pulmonary and Respiratory Medicine and 61 papers in Molecular Medicine on the topics of Antibiotic Resistance in Bacteria (59 papers), Pulmonary Hypertension Research and Treatments (48 papers) and Enterobacteriaceae and Cronobacter Research (20 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (8.3k citations), Molecular Biology (5.8k citations) and Cardiology and Cardiovascular Medicine (5.6k citations). Authors at Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition. Some of Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique's most productive authors include Thierry Naas, Gérald Simonneau, Elias Fattal, Laurent Dortet and Nicolas Tsapis

In The Last Decade

Rankless by CCL
2025